Look for:

Our offer for

BIOGEN IDEC INC.


ISIN:
US09062X1037
WKN:
09062X103

2019/12/12 22:00:00
Price
293.85 USD
Difference 0.55% (1.62)

General attributes

ISINUS09062X1037
SymbolBIIB
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)58,013 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)291.37 USD (200)
Ask (Ask size)295.97 USD (600)
Open291.94 USD
High296.17 USD
Low290.93 USD
Close (prev. day)292.23 USD
VWAP293.492219 USD
Volume (pcs)1,951,022
Trading volume572,716,072.59
Number of trades28,474
Last size96,604

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: BIOGEN IDEC INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2019/12/12 22:00:00
Price
293.85 USD
Difference 0.55% (1.62)

General attributes

ISINUS09062X1037
SymbolBIIB
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)58,013 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)291.37 USD (200)
Ask (Ask size)295.97 USD (600)
Open291.94 USD
High296.17 USD
Low290.93 USD
Close (prev. day)292.23 USD
VWAP293.492219 USD
Volume (pcs)1,951,022
Trading volume572,716,072.59
Number of trades28,474
Last size96,604

Performance and Risk

6m1Y3Y
Perf (%)+27.57%-8.62%+10.19%
Perf (abs.)+63.15-27.56+27.03
Beta0.790.730.93
Volatility40.5849.9437.27
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)296.93 USD (2,575,819)
Ø price 30 days | Ø volume 30 days (pcs.)292.81 USD (1,883,250)
Ø price 100 days | Ø volume 100 days (pcs.)252.80 USD (1,927,100)
Ø price 250 days | Ø volume 250 days (pcs.)263.12 USD (1,915,877)
YTD High | date344.00 USD (2019/01/23)
YTD Low | date215.78 USD (2019/09/04)
52 Weeks High | date344.00 USD (2019/01/23)
52 Weeks Low | date215.78 USD (2019/09/04)

All listings for BIOGEN IDEC INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2019/12/1217:35264.10 EUR0.012
Vienna Stock Exchange2019/12/1217:32264.55 EUR0.002
Tradegate2019/12/1222:26263.90 EUR0.3321
Stuttgart2019/12/1217:01264.05 EUR0.005
SIX Swiss Exchange2019/07/0217:35232.00 CHF0.001
Nasdaq2019/12/1222:00293.85 USD572.7228,474
Munich2019/12/1208:01261.25 EUR0.002
London Stock Exchange2019/11/0114:47300.2939 USD0.011
Hanover2019/12/1208:09261.25 EUR0.002
Hamburg2019/12/1208:09261.25 EUR0.002
Frankfurt2019/12/1216:05264.70 EUR0.0137
Duesseldorf2019/12/1217:06264.00 EUR0.005
Berlin2019/12/1219:35263.20 EUR0.0013

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2033&ID_TYPE_IMAGE_LOGO=2

Contact Details

BIOGEN INC.
Joe Mara
Binney Street 225 02142 Cambridge, Massachusetts
Telefon: +1-671-679-2000
Fax: +1-617-679-2617
E-mail: IR@biogenidec.com

PDF Downloads

Company report: BIOGEN IDEC INC.PDF Download

Company Profile

Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world's oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies.

Members of Management Board

Stelios PapadopoulosChairman of Board of Directors
William A. HawkinsMember of Board of Directors
The Honorable Lynn SchenkMember of Board of Directors
Stephen A. SherwinMember of Board of Directors
Robert W. PangiaMember of Board of Directors
Nancy L. LeamingMember of Board of Directors
Michel VounatsosMember of Board of Directors
Jesus B. MantasMember of Board of Directors
Eric K. RowinskyMember of Board of Directors
Caroline DorsaMember of Board of Directors
Brian S. PosnerMember of Board of Directors
Richard C. MulliganMember of Board of Directors
Alexander J. DennerMember of Board of Directors
Michel VounatsosChairman of Managing Board
Susan H. AlexanderMember of Executive Committee
Jeffrey D. CapelloMember of Executive Committee
Daniel KarpMember of Executive Committee
Chirfi GuindoMember of Executive Committee
Alphonse GaldesMember of Executive Committee
Alfred SandrockMember of Executive Committee
Ginger GregoryMember of Executive Committee






Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer